The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Influenza virus hemagglutinin stalk-based antibodies and vaccines
Open accessAbstract
Antibodies against the conserved stalk domain of the hemagglutinin are currently being discussed as promising therapeutic tools against influenza virus infections. Due to the conservation of the stalk domain these antibodies are able to broadly neutralize a wide spectrum of influenza virus strains and subtypes. Broadly protective vaccine candidates based on the epitopes of these antibodies, e.g. chimeric and headless hemagglutinin structures, are currently under development and show promising results in animals models. These candidates could be developed into universal influenza virus vaccines that protect from infection with drifted seasonal as well as novel pandemic influenza virus strains therefore obviating the need for annual vaccination, and enhancing our pandemic preparedness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
Gao, R., Cao, B., Hu, Y., Feng, Z., Wang, D., Hu, W., Chen, J., Jie, Z., Qiu, H., Xu, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304459 · Cited by 2,310
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Ekiert, D. C., Bhabha, G., Elsliger, M.-A., Friesen, R. H. E., Jongeneelen, M., Throsby, M., Goudsmit, J., & Wilson, I. A. (2009) · Science · doi:10.1126/science.1171491 · Cited by 1,326
Corti, D., Voss, J., Gamblin, S. J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S. G., Pinna, D., Minola, A., Vanzetta, F., et al. (2011) · Science · doi:10.1126/science.1205669 · Cited by 1,203 · cited 5×
“The vast majority of stalk reactive antibodies (including CR6261, F10, FI6 and C179) share a common footprint on the stalk domain [16–19,20 ].”
InfluentialSui, J., Hwang, W. C., Perez, S., Wei, G., Aird, D., Chen, L.-M., Santelli, E., Stec, B., Cadwell, G., Ali, M., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1566 · Cited by 1,130
Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
Wrammert, J., Smith, K., Miller, J., Langley, W. A., Kokko, K., Larsen, C., Zheng, N.-Y., Mays, I., Garman, L., Helms, C., et al. (2008) · Nature · doi:10.1038/nature06890 · Cited by 1,025
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Kanekiyo, M., Wei, C.-J., Yassine, H. M., McTamney, P. M., Boyington, J. C., Whittle, J. R. R., Rao, S. S., Kong, W.-P., Wang, L., & Nabel, G. J. (2013) · Nature · doi:10.1038/nature12202 · Cited by 885
Highly Conserved Protective Epitopes on Influenza B Viruses
Dreyfus, C., Laursen, N. S., Kwaks, T., Zuijdgeest, D., Khayat, R., Ekiert, D. C., Lee, J. H., Metlagel, Z., Bujny, M. V., Jongeneelen, M., et al. (2012) · Science · doi:10.1126/science.1222908 · Cited by 866
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
Ekiert, D. C., Friesen, R. H. E., Bhabha, G., Kwaks, T., Jongeneelen, M., Yu, W., Ophorst, C., Cox, F., Korse, H. J. W. M., Brandenburg, B., et al. (2011) · Science · doi:10.1126/science.1204839 · Cited by 822
Wrammert, J., Koutsonanos, D., Li, G.-M., Edupuganti, S., Sui, J., Morrissey, M., McCausland, M., Skountzou, I., Hornig, M., Lipkin, W. I., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101352 · Cited by 777
Throsby, M., van den Brink, E., Jongeneelen, M., Poon, L. L. M., Alard, P., Cornelissen, L., Bakker, A., Cox, F., van Deventer, E., Guan, Y., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003942 · Cited by 737
Bridges, C. B., Thompson, W. W., Meltzer, M. I., Reeve, G. R., Talamonti, W. J., Cox, N. J., Lilac, H. A., Hall, H., Klimov, A., & Fukuda, K. (2000) · JAMA · doi:10.1001/jama.284.13.1655 · Cited by 651
Influenza-Associated Deaths among Children in the United States, 2003–2004
Bhat, N., Wright, J. G., Broder, K. R., Murray, E. L., Greenberg, M. E., Glover, M. J., Likos, A. M., Posey, D. L., Klimov, A., Lindstrom, S. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051721 · Cited by 648 · cited 1×
“Vaccine strain prediction based on surveillance is a complicated and error prone process and produces mismatches between circulating virus and vaccine strains from time to time which leads to a severe drop in efficacy of the seasonal influenza virus vaccines [8– 12].”
Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
Steel, J., Lowen, A. C., Wang, T. T., Yondola, M., Gao, Q., Haye, K., García-Sastre, A., & Palese, P. (2010) · mBio · doi:10.1128/mbio.00018-10 · Cited by 533
Self-citationThe annual production cycle for influenza vaccine
Gerdil, C. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00071-9 · Cited by 529
Okuno, Y., Isegawa, Y., Sasao, F., & Ueda, S. (1993) · Journal of Virology · doi:10.1128/jvi.67.5.2552-2558.1993 · Cited by 489
Corti, D., Suguitan, A. L., Pinna, D., Silacci, C., Fernandez-Rodriguez, B. M., Vanzetta, F., Santos, C., Luke, C. J., Torres-Velez, F. J., Temperton, N. J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41902 · Cited by 437
Krammer, F., Pica, N., Hai, R., Margine, I., & Palese, P. (2013) · Journal of Virology · doi:10.1128/jvi.00641-13 · Cited by 423
Self-citationLi, G.-M., Chiu, C., Wrammert, J., McCausland, M., Andrews, S. F., Zheng, N.-Y., Lee, J.-H., Huang, M., Qu, X., Edupuganti, S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118979109 · Cited by 393
Hu, Y., Lu, S., Song, Z., Wang, W., Hao, P., Li, J., Zhang, X., Yen, H.-L., Shi, B., Li, T., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61125-3 · Cited by 355
Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination
Wei, C.-J., Boyington, J. C., McTamney, P. M., Kong, W.-P., Pearce, M. B., Xu, L., Andersen, H., Rao, S., Tumpey, T. M., Yang, Z.-Y., et al. (2010) · Science · doi:10.1126/science.1192517 · Cited by 337
Wang, T. T., Tan, G. S., Hai, R., Pica, N., Ngai, L., Ekiert, D. C., Wilson, I. A., García-Sastre, A., Moran, T. M., & Palese, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013387107 · Cited by 302
Self-citationInfluenza Hemagglutination-Inhibition Antibody Titer as a Correlate of Vaccine-Induced Protection
Ohmit, S. E., Petrie, J. G., Cross, R. T., Johnson, E., & Monto, A. S. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir661 · Cited by 296
Hai, R., Krammer, F., Tan, G. S., Pica, N., Eggink, D., Maamary, J., Margine, I., Albrecht, R. A., & Palese, P. (2012) · Journal of Virology · doi:10.1128/jvi.00137-12 · Cited by 278
Self-citationWang, T. T., Tan, G. S., Hai, R., Pica, N., Petersen, E., Moran, T. M., & Palese, P. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000796 · Cited by 278
Self-citationSteel, J., Lowen, A. C., Pena, L., Angel, M., Solórzano, A., Albrecht, R., Perez, D. R., García-Sastre, A., & Palese, P. (2009) · Journal of Virology · doi:10.1128/jvi.01920-08 · Cited by 258
Self-citationNordin, J., Mullooly, J., Poblete, S., Strikas, R., Petrucci, R., Wei, F., Rush, B., Safirstein, B., Wheeler, D., & Nichol, K. L. (2001) · The Journal of Infectious Diseases · doi:10.1086/323085 · Cited by 251
Pica, N., Hai, R., Krammer, F., Wang, T. T., Maamary, J., Eggink, D., Tan, G. S., Krause, J. C., Moran, T., Stein, C. R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200039109 · Cited by 250
Self-citationde Jong, J. C., Beyer, W. E. P., Palache, A. M., Rimmelzwaan, G. F., & Osterhaus, A. D. M. E. (2000) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(200005)61:1<94::aid-jmv15>3.0.co;2-c · Cited by 230
Jegaskanda, S., Job, E. R., Kramski, M., Laurie, K., Isitman, G., de Rose, R., Winnall, W. R., Stratov, I., Brooks, A. G., Reading, P. C., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201574 · Cited by 215
Bommakanti, G., Citron, M. P., Hepler, R. W., Callahan, C., Heidecker, G. J., Najar, T. A., Lu, X., Joyce, J. G., Shiver, J. W., Casimiro, D. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007465107 · Cited by 214
Krause, J. C., Tsibane, T., Tumpey, T. M., Huffman, C. J., Basler, C. F., & Crowe, J. E. (2011) · Journal of Virology · doi:10.1128/jvi.00700-11 · Cited by 204
Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses
Margine, I., Krammer, F., Hai, R., Heaton, N. S., Tan, G. S., Andrews, S. A., Runstadler, J. A., Wilson, P. C., Albrecht, R. A., García-Sastre, A., et al. (2013) · Journal of Virology · doi:10.1128/jvi.01715-13 · Cited by 197
Self-citationMiller, M. S., Gardner, T. J., Krammer, F., Aguado, L. C., Tortorella, D., Basler, C. F., & Palese, P. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006637 · Cited by 190
Self-citationJegaskanda, S., Weinfurter, J. T., Friedrich, T. C., & Kent, S. J. (2013) · Journal of Virology · doi:10.1128/jvi.03030-12 · Cited by 183
Krammer, F., Margine, I., Tan, G. S., Pica, N., Krause, J. C., & Palese, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043603 · Cited by 173
Self-citationMoody, M. A., Zhang, R., Walter, E. B., Woods, C. W., Ginsburg, G. S., McClain, M. T., Denny, T. N., Chen, X., Munshaw, S., Marshall, D. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025797 · Cited by 165
Margine, I., Hai, R., Albrecht, R. A., Obermoser, G., Harrod, A. C., Banchereau, J., Palucka, K., García-Sastre, A., Palese, P., Treanor, J. J., et al. (2013) · Journal of Virology · doi:10.1128/jvi.03509-12 · Cited by 163
Self-citationA Pan-H1 Anti-Hemagglutinin Monoclonal Antibody with Potent Broad-Spectrum Efficacy In Vivo
Tan, G. S., Krammer, F., Eggink, D., Kongchanagul, A., Moran, T. M., & Palese, P. (2012) · Journal of Virology · doi:10.1128/jvi.00469-12 · Cited by 161
Self-citationGraves, P. N., Schulman, J. L., Young, J. F., & Palese, P. (1983) · Virology · doi:10.1016/0042-6822(83)90465-8 · Cited by 142
Self-citationAssessment of Influenza Virus Hemagglutinin Stalk-Based Immunity in Ferrets
Krammer, F., Hai, R., Yondola, M. A., Tan, G. S., Leyva-Grado, V. H., Ryder, A. B., Miller, M. S., Rose, J. K., Palese, P., García‐Sastre, A., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03004-13 · Cited by 134
Self-citationWhy Do Influenza Virus Subtypes Die Out? A Hypothesis
Palese, P., & Wang, T. T. (2011) · mBio · doi:10.1128/mbio.00150-11 · Cited by 115
Self-citationThomson, C. A., Wang, Y., Jackson, L. M., Olson, M., Wang, W., Liavonchanka, A., Keleta, L., da Silva, V. G. L., Diederich, S., Jones, R. B., et al. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00087 · Cited by 114
Huber, M., Fischer, M., Misselwitz, B., Manrique, A., Kuster, H., Niederöst, B., Weber, R. K., von Wyl, V., Günthard, H. F., & Trkola, A. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030441 · Cited by 113
Dreyfus, C., Ekiert, D. C., & Wilson, I. A. (2013) · Journal of Virology · doi:10.1128/jvi.02975-12 · Cited by 111
Harris, A. K., Meyerson, J. R., Matsuoka, Y., Kuybeda, O., Moran, A., Bliss, D., Das, S. R., Yewdell, J. W., Sapiro, G., Subbarao, K., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214913110 · Cited by 107
Terajima, M., Cruz, J., Co, M. D. T., Lee, J.-H., Kaur, K., Wilson, P. C., & Ennis, F. A. (2011) · Journal of Virology · doi:10.1128/jvi.05193-11 · Cited by 104
Friesen, R. H. E., Koudstaal, W., Koldijk, M. H., Weverling, G. J., Brakenhoff, J. P. J., Lenting, P. J., Stittelaar, K. J., Osterhaus, A. D. M. E., Kompier, R., & Goudsmit, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009106 · Cited by 103
Krammer, F., Pica, N., Hai, R., Tan, G. S., & Palese, P. (2012) · Journal of Virology · doi:10.1128/jvi.01336-12 · Cited by 97
Self-citationHuman Monoclonal Antibodies Broadly Neutralizing against Influenza B Virus
Yasugi, M., Kubota‐Koketsu, R., Yamashita, A., Kawashita, N., Du, A., Sasaki, T., Nishimura, M., Misaki, R., Kuhara, M., Boonsathorn, N., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003150 · Cited by 87
Schneemann, A., Speir, J. A., Tan, G. S., Khayat, R., Ekiert, D. C., Matsuoka, Y., & Wilson, I. A. (2012) · Journal of Virology · doi:10.1128/jvi.01694-12 · Cited by 82
1976 and 2009 H1N1 Influenza Virus Vaccines Boost Anti-Hemagglutinin Stalk Antibodies in Humans
Miller, M. S., Tsibane, T., Krammer, F., Hai, R., Rahmat, S., Basler, C. F., & Palese, P. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis652 · Cited by 77
Self-citationElicitation of Broadly Neutralizing Influenza Antibodies in Animals with Previous Influenza Exposure
Wei, C., Yassine, H. M., McTamney, P. M., Gall, J. G. D., Whittle, J. R. R., Boyington, J. C., & Nabel, G. J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004273 · Cited by 64
Sangster, M. Y., Baer, J., Santiago, F. W., Fitzgerald, T. F., Ilyushina, N. A., Sundararajan, A., Henn, A. D., Krammer, F., Yang, H., Luke, C. J., et al. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00735-12 · Cited by 64
Self-citationGocník, M., Fislová, T., Mucha, V., et al. (2008) · Journal of General Virology · doi:10.1099/vir.0.83524-0 · Cited by 59
Surveillance and impact of influenza in the United States.
Klimov, A., Simonsen, L., Fukuda, K., & Cox, N. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00104-8 · Cited by 57
Hashem, A. M., Domselaar, G. V., Li, C., Wang, J., She, Y., Cyr, T. D., Sui, J., He, R., Marasco, W. A., & Li, X. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.030 · Cited by 52
Desbien, A. L., Hoeven, N. V., Reed, J., Casey, A. C., Laurance, J. D., Baldwin, S. L., Duthie, M. S., Reed, S. G., & Carter, D. (2013) · BioTechniques · doi:10.2144/000114041 · Cited by 23
Hurt, A. C., Leang, S. K., Tiedemann, K., et al. (2013) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12108 · Cited by 23
Oseltamivir‐resistant 2009 H1N1 influenza pneumonia during therapy in a renal transplant recipient
Shetty, A. K., Ross, G. A., Pranikoff, T., Gubareva, L. V., Sechrist, C. W., Guirand, D. M., Abramson, J. S., & Lin, J. (2011) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2011.01489.x · Cited by 19
DeVries, A., Wotton, J. T., Lees, C., Boxrud, D. J., Uyeki, T. M., & Lynfield, R. (2012) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2011.00329.x · Cited by 12
Cited by
Krammer, F., Smith, G. J. D., Fouchier, R. A. M., Peiris, M., Kedzierska, K., Doherty, P. C., Palese, P., Shaw, M. L., Treanor, J., Webster, R. G., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0002-y · Cited by 1,570
Self-citationThe human antibody response to influenza A virus infection and vaccination
Krammer, F. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0143-6 · Cited by 796
Self-citationAdvances in the development of influenza virus vaccines
Krammer, F., & Palese, P. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4529 · Cited by 597
Self-citationmRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
Maruggi, G., Zhang, C., Li, J., Ulmer, J. B., & Yu, D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.01.020 · Cited by 507
Immune history profoundly affects broadly protective B cell responses to influenza
Andrews, S. F., Huang, Y., Kaur, K., Popova, L. I., Ho, I. Y., Pauli, N. T., Dunand, C. J. H., Taylor, W. M., Lim, S., Huang, M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad0522 · Cited by 411
Self-citation
Metadata
- Authors
- Krammer, F., & Palese, P.
- Venue
- Current Opinion in Virology
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 3
- Issue
- 5
- Pages
- 521-530
- ISSN
- 1879-6257 (ISSN-L)
- OpenAlex
- W2021537447
- Cited by
- 326
- References
- 60
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.